150 related articles for article (PubMed ID: 31201672)
1. Quality of life in patients with polyneuropathy associated with different types of monoclonal gammopathy of undetermined significance.
Opalic M; Peric S; Palibrk A; Bozovic I; Bjelica B; Stevic Z; Basta I
Acta Neurol Belg; 2020 Oct; 120(5):1133-1138. PubMed ID: 31201672
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with multifocal motor neuropathy from Serbia.
Bozovic I; Peric S; Basta I; Kacar A; Nikolic A; Belanovic B; Lavrnic D; Rakocevic-Stojanovic V; Stevic Z
J Neurol Sci; 2019 Apr; 399():151-154. PubMed ID: 30818075
[TBL] [Abstract][Full Text] [Related]
3. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
[TBL] [Abstract][Full Text] [Related]
4. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance].
Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S
Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652
[TBL] [Abstract][Full Text] [Related]
5. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
[TBL] [Abstract][Full Text] [Related]
6. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
Niermeijer JM; Fischer K; Eurelings M; Franssen H; Wokke JH; Notermans NC
Neurology; 2010 Feb; 74(5):406-12. PubMed ID: 20124206
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinical and neurophysiological findings with health-related quality of life in patients with diabetic polyneuropathy.
Vukojević Z; Pekmezović T; Nikolić A; Perić S; Basta I; Marjanović I; Lavrnić D
Vojnosanit Pregl; 2014 Sep; 71(9):833-8. PubMed ID: 25282781
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
11. Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.
Niermeijer JM; Eurelings M; van der Linden MW; Lokhorst HM; Franssen H; Fischer K; Teunissen LL; van den Berg LH; Schobben F; Wokke JH; Notermans NC
Neurology; 2007 Jul; 69(1):50-9. PubMed ID: 17606880
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and progression risk factors for patients with monoclonal gammopathy of undetermined significance].
Guan A; Shen KN; Zhang L; Cao XX; Su W; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):137-140. PubMed ID: 36948868
[No Abstract] [Full Text] [Related]
13. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
[TBL] [Abstract][Full Text] [Related]
14. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
[TBL] [Abstract][Full Text] [Related]
15. [A case of sensory ataxic axonal polyneuropathy with IgGλ monoclonal gammopathy successfully treated with intravenous immunoglobulin therapy].
Kanatsuka Y; Hasegawa O; Imazeki R; Yamamoto M
Rinsho Shinkeigaku; 2015; 55(5):349-52. PubMed ID: 26028199
[TBL] [Abstract][Full Text] [Related]
16. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.
Galassi G; Tondelli M; Ariatti A; Benuzzi F; Nichelli P; Valzania F
Int J Neurosci; 2017 May; 127(5):439-447. PubMed ID: 27188752
[TBL] [Abstract][Full Text] [Related]
17. IgM-monoclonal gammopathy neuropathy and tremor: a first epidemiologic case control study.
Ahlskog MC; Kumar N; Mauermann ML; Klein CJ
Parkinsonism Relat Disord; 2012 Jul; 18(6):748-52. PubMed ID: 22475624
[TBL] [Abstract][Full Text] [Related]
18. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S
J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732
[TBL] [Abstract][Full Text] [Related]
19. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
[TBL] [Abstract][Full Text] [Related]
20. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
Suarez GA; Kelly JJ
Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
